Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery
Steven D. Gore, Albert D. Donnenberg, Barbara A. Zehnbauer, Li Jun Weng, Philip J. Burke
Dive into the research topics of 'Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery'. Together they form a unique fingerprint.